NKTR

NEKTAR THERAPEUTICS

Sales chart range
Log in to watch NKTR
Latest sale
$15k
Nov 17 · No plan
Form 4 sales
385
On record
Form 144 notices
8
Proposed sales
Next unlock
None
No lockup ahead

Lockups

No lockup on record.

Sales by reason

0
Routine
0
Plan not stated
2
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Timeline

  1. 1 Form 4 saleNo plan
    May 19 2026

    Sold 199 shares at $65.51 ($13k)

    Zalevsky Jonathan, Chief R&D Officer

    No 10b5-1 planSold 0.9% of holdings ($1.4M position)20,975 shares left0.1x usual sizeFiling

  2. 2 Form 4 saleRoutine
    Jun 15 +27 days

    Sold 5,538 shares at $60.71 ($336k)

    Zalevsky Jonathan, Chief R&D Officer

    10b5-1 planSold 26.4% of holdings ($1.3M position)15,437 shares left2x usual sizeFiling

  3. 3 Form 4 saleRoutine
    Jun 17 +2 days

    Sold 20,000 shares at $60.75 ($1.2M)

    Robin Howard W, President & CEO

    10b5-1 planSold 26.7% of holdings ($4.6M position)55,045 shares left2.2x usual sizeFiling

  4. 4 Form 4 saleRoutine
    Jun 30 +13 days

    Sold 5,681 shares at $70.00 ($398k)

    Zalevsky Jonathan, Chief R&D Officer

    10b5-1 planSold 36.8% of holdings ($1.1M position)9,756 shares left1.5x usual sizeFiling

  5. 5 Form 4 saleNo plan
    Aug 18 +49 days

    Sold 418 shares at $71.98 ($30k)

    Robin Howard W, President & CEO

    No 10b5-1 planSold 0.8% of holdings ($4M position)54,627 shares left0x usual sizeFiling

  6. 6 Form 4 saleNo plan
    Aug 18 same day

    Sold 186 shares at $71.98 ($13k)

    Zalevsky Jonathan, Chief R&D Officer

    No 10b5-1 planSold 1.9% of holdings ($702k position)9,570 shares left0x usual sizeFiling

  7. 7 Form 4 saleNo plan
    Nov 17 +91 days

    Sold 192 shares at $35.85 ($7k)

    Zalevsky Jonathan, Chief R&D Officer

    No 10b5-1 planSold 2% of holdings ($343k position)9,378 shares left0.1x usual sizeFiling

  8. 8 Form 4 saleNo plan
    Nov 17 same day

    Sold 429 shares at $35.85 ($15k)

    Robin Howard W, President & CEO

    No 10b5-1 planSold 0.8% of holdings ($2M position)54,198 shares left0.1x usual sizeFiling

Every transaction

Loading transactions…

Sales, notices and lockups (393)

Export watchlist as CSV
Lockups, Form 144 notices and Form 4 sales for NKTR
Source
Nov 17, 2026Robin Howard WPresident & CEOForm 4 sale429$15k0.8%No planSEC
Nov 17, 2026Zalevsky JonathanChief R&D OfficerForm 4 sale192$7k2.0%No planSEC
Aug 18, 2026Zalevsky JonathanChief R&D OfficerForm 4 sale186$13k1.9%No planSEC
Aug 18, 2026Robin Howard WPresident & CEOForm 4 sale418$30k0.8%No planSEC
Jun 30, 2026Zalevsky JonathanChief R&D OfficerForm 4 sale5,681$398k36.8%RoutineSEC
Jun 17, 2026Robin Howard WPresident & CEOForm 4 sale20,000$1.2M26.7%RoutineSEC
Jun 15, 2026Zalevsky JonathanChief R&D OfficerForm 4 sale5,538$336k26.4%RoutineSEC
May 19, 2026Zalevsky JonathanChief R&D OfficerForm 4 sale199$13k0.9%No planSEC
May 19, 2026Robin Howard WPresident & CEOForm 4 sale444$29k0.6%No planSEC
Feb 18, 2026Zalevsky JonathanChief R&D OfficerForm 4 sale180$13k0.8%No planSEC
Feb 18, 2026Robin Howard WPresident & CEOForm 4 sale423$31k0.6%No planSEC
Jan 20, 2026Zalevsky JonathanChief R&D OfficerForm 4 sale3,867$138k15.3%RoutineSEC
Nov 25, 2025Zalevsky JonathanChief R&D OfficerForm 4 sale1,157$63k5.7%No planSEC
Nov 25, 2025Wilson Mark AndrewChief Legal OfficerForm 4 sale630$34k2.8%No planSEC
Nov 25, 2025Robin Howard WPresident & CEOForm 4 sale2,207$120k3.9%No planSEC
Sep 9, 2025Robin Howard WPresident & CEOForm 4 sale6,666$311k11.9%RoutineSEC
Sep 5, 2025Robin Howard WPresident & CEOForm 4 sale11,832$431k17.4%RoutineSEC
Sep 4, 2025Zalevsky JonathanChief R&D OfficerForm 4 sale1,721$58k9.0%RoutineSEC
Sep 2, 2025Zalevsky JonathanChief R&D OfficerForm 4 sale485$15k2.5%RoutineSEC
Sep 2, 2025Robin Howard WPresident & CEOForm 4 sale1,500$45k2.2%RoutineSEC
Aug 19, 2025Zalevsky JonathanChief R&D OfficerForm 4 sale725$19k3.6%No planSEC
Aug 19, 2025Wilson Mark AndrewChief Legal OfficerForm 4 sale676$18k3.2%No planSEC
Aug 19, 2025Robin Howard WPresident & CEOForm 4 sale1,573$42k2.2%No planSEC
May 19, 2025Zalevsky JonathanChief R&D OfficerForm 4 sale10,712$7k3.4%No planSEC
May 19, 2025Wilson Mark AndrewChief Legal OfficerForm 4 sale9,996$7k3.1%No planSEC
May 19, 2025Robin Howard WPresident & CEOForm 4 sale23,208$16k2.1%No planSEC
Feb 19, 2025Zalevsky JonathanChief R&D OfficerForm 4 sale10,300$10k3.2%No planSEC
Feb 19, 2025Wilson Mark AndrewChief Legal OfficerForm 4 sale11,040$11k3.3%No planSEC
Feb 19, 2025Robin Howard WPresident & CEOForm 4 sale23,774$24k2.1%No planSEC
Dec 24, 2024Wilson Mark AndrewChief Legal OfficerForm 4 sale49,962$45k13.0%UnusualSEC
Dec 19, 2024Zalevsky JonathanChief R&D OfficerForm 4 sale51,115$48k13.5%UnusualSEC
Dec 19, 2024Zalevsky JonathanOfficerForm 144 notice51,115$48kNoticeSEC
Dec 18, 2024Robin Howard WPresident & CEOForm 4 sale132,030$132k10.6%No planSEC
Dec 18, 2024Robin Howard WOfficer, DirectorForm 144 notice85,035$84kNoticeSEC
Dec 17, 2024Robin Howard WOfficer, DirectorForm 144 notice46,995$47kNoticeSEC
Nov 19, 2024Zalevsky JonathanChief R&D OfficerForm 4 sale7,785$8k3.1%No planSEC
Nov 19, 2024Wilson Mark AndrewChief Legal OfficerForm 4 sale6,407$6k2.8%No planSEC
Nov 19, 2024Robin Howard WPresident & CEOForm 4 sale16,278$16k1.9%No planSEC
Aug 19, 2024Zalevsky JonathanChief R&D OfficerForm 4 sale6,866$9k2.7%No planSEC
Aug 19, 2024Wilson Mark AndrewChief Legal OfficerForm 4 sale5,651$7k2.4%No planSEC
Aug 19, 2024Robin Howard WPresident & CEOForm 4 sale14,881$19k1.7%No planSEC
Jun 14, 2024Chess RobertDirectorForm 4 sale19,500$23k7.1%RoutineSEC
May 17, 2024Robin Howard WPresident & CEOForm 4 sale16,650$29k1.9%No planSEC
May 17, 2024Zalevsky JonathanChief R&D OfficerForm 4 sale7,355$13k2.8%No planSEC
May 17, 2024Wilson Mark AndrewChief Legal OfficerForm 4 sale6,260$11k2.6%No planSEC
May 10, 2024Kroin David10% ownerForm 4 sale56,000$100k0.3%No planSEC
Feb 20, 2024Zalevsky JonathanChief R&D OfficerForm 4 sale9,014$6k3.3%No planSEC
Feb 20, 2024Wilson Mark AndrewChief Legal OfficerForm 4 sale7,606$5k3.1%No planSEC
Feb 20, 2024Robin Howard WPresident & CEOForm 4 sale20,033$14k2.2%No planSEC
Nov 17, 2023Zalevsky JonathanChief R&D OfficerForm 4 sale9,646$5k3.4%No planSEC
Nov 17, 2023Wilson Mark AndrewChief Legal OfficerForm 4 sale7,179$4k2.9%No planSEC
Nov 17, 2023Robin Howard WPresident & CEOForm 4 sale19,877$10k2.2%No planSEC
Nov 17, 2023Zalevsky JonathanOfficerForm 144 notice9,646$5kNoticeSEC
Nov 17, 2023Wilson Mark AndrewOfficerForm 144 notice7,179$4kNoticeSEC
Nov 17, 2023Robin Howard WOfficer, DirectorForm 144 notice19,877$10kNoticeSEC
Sep 18, 2023Curet MyriamDirectorForm 4 sale4,359$3k13.7%No planSEC
Sep 18, 2023Ajer Jeffrey RobertDirectorForm 4 sale4,359$3k11.3%No planSEC
Sep 18, 2023Chess RobertDirectorForm 144 notice10,200$7kNoticeSEC
Aug 16, 2023Zalevsky JonathanChief R&D OfficerForm 4 sale9,703$8k3.3%No planSEC
Aug 16, 2023Wilson Mark AndrewChief Legal OfficerForm 4 sale7,221$6k2.8%No planSEC
Aug 16, 2023Robin Howard WPresident & CEOForm 4 sale19,998$16k2.1%No planSEC
Jun 14, 2023Whitfield Roy ADirectorForm 4 sale30,000$17k12.2%RoutineSEC
Jun 14, 2023Whitfield Roy ADirectorForm 144 notice30,000$17kNoticeSEC
May 16, 2023Zalevsky JonathanChief R&D OfficerForm 4 sale9,791$7k3.2%No planSEC
May 16, 2023Wilson Mark AndrewChief Legal OfficerForm 4 sale7,543$5k2.8%No planSEC
May 16, 2023Robin Howard WPresident & CEOForm 4 sale20,361$15k2.1%No planSEC
Feb 16, 2023Zalevsky JonathanChief R&D OfficerForm 4 sale10,484$31k3.3%Plan not statedSEC
Feb 16, 2023Wilson Mark AndrewChief Legal OfficerForm 4 sale8,275$25k3.0%Plan not statedSEC
Feb 16, 2023Thomsen Jillian B.Chief Financial OfficerForm 4 sale10,267$31k3.2%Plan not statedSEC
Feb 16, 2023Robin Howard WPresident & CEOForm 4 sale19,635$59k2.0%Plan not statedSEC
Nov 16, 2022Zalevsky JonathanChief R&D OfficerForm 4 sale13,460$48k4.1%Plan not statedSEC
Nov 16, 2022Wilson Mark AndrewChief Legal OfficerForm 4 sale8,690$31k3.1%Plan not statedSEC
Nov 16, 2022Thomsen Jillian B.Chief Financial OfficerForm 4 sale11,095$40k3.3%Plan not statedSEC
Nov 16, 2022Robin Howard WPresident & CEOForm 4 sale38,014$136k3.7%UnusualSEC
Sep 23, 2022Curet MyriamDirectorForm 4 sale4,198$13k11.7%Plan not statedSEC
Sep 23, 2022Ajer Jeffrey RobertDirectorForm 4 sale4,198$13k9.8%Plan not statedSEC
Sep 22, 2022Chess RobertDirectorForm 4 sale10,200$7k3.6%RoutineSEC
Sep 22, 2022Chess RobertDirectorForm 4 sale5,100$16k2.2%Plan not statedSEC
Sep 13, 2022Eastham KarinDirectorForm 4 sale21,267$77k62.0%UnusualSEC
Aug 18, 2022Zalevsky JonathanChief R&D OfficerForm 4 sale73,716$343k18.4%UnusualSEC
Aug 16, 2022Zalevsky JonathanChief R&D OfficerForm 4 sale10,560$50k2.6%Plan not statedSEC
Aug 16, 2022Wilson Mark AndrewSVP & General CounselForm 4 sale3,189$15k1.1%Plan not statedSEC
Aug 16, 2022Thomsen Jillian B.SVP & Chief Accounting OfficerForm 4 sale2,006$10k0.6%Plan not statedSEC
Aug 16, 2022Robin Howard WPresident & CEOForm 4 sale13,759$65k1.3%Plan not statedSEC
May 16, 2022Zalevsky JonathanChief R&D OfficerForm 4 sale21,673$86k7.3%Plan not statedSEC
May 16, 2022Wilson Mark AndrewSVP & General CounselForm 4 sale3,136$12k2.6%Plan not statedSEC
May 16, 2022Thomsen Jillian B.SVP & Chief Accounting OfficerForm 4 sale5,841$23k3.3%Plan not statedSEC
May 16, 2022Robin Howard WPresident & CEOForm 4 sale36,529$144k5.6%UnusualSEC
May 16, 2022Northcott JohnSVP & Chief Commercial OfficerForm 4 sale4,592$18k2.0%Plan not statedSEC
May 16, 2022Labrucherie Gil MSVP, COO & CFOForm 4 sale17,448$69k5.3%Plan not statedSEC
Feb 16, 2022Zalevsky JonathanChief R&D OfficerForm 4 sale10,912$119k3.8%Plan not statedSEC
Feb 16, 2022Wilson Mark AndrewSVP & General CounselForm 4 sale3,661$40k2.9%Plan not statedSEC
Feb 16, 2022Thomsen Jillian B.SVP & Chief Accounting OfficerForm 4 sale2,363$26k1.4%Plan not statedSEC
Feb 16, 2022Robin Howard WPresident & CEOForm 4 sale12,480$137k2.1%Plan not statedSEC
Feb 16, 2022Northcott JohnSVP & Chief Commercial OfficerForm 4 sale4,852$53k2.1%Plan not statedSEC
Feb 16, 2022Labrucherie Gil MSVP, COO & CFOForm 4 sale7,579$83k2.5%Plan not statedSEC
Nov 18, 2021Labrucherie Gil MSVP, COO & CFOForm 4 sale24,149$316k8.6%Plan not statedSEC
Nov 16, 2021Zalevsky JonathanChief R&D OfficerForm 4 sale20,869$275k8.3%Plan not statedSEC
Nov 16, 2021Wilson Mark AndrewSVP & General CounselForm 4 sale6,564$86k7.1%UnusualSEC
Nov 16, 2021Thomsen Jillian B.SVP & Chief Accounting OfficerForm 4 sale6,741$89k4.4%Plan not statedSEC
Nov 16, 2021Robin Howard WPresident & CEOForm 4 sale42,773$563k8.3%UnusualSEC
Nov 16, 2021Northcott JohnSVP & Chief Commercial OfficerForm 4 sale6,061$80k3.0%Plan not statedSEC
Sep 22, 2021Curet MyriamDirectorForm 4 sale3,665$65k12.4%Plan not statedSEC
Sep 22, 2021Chess RobertDirectorForm 4 sale4,600$83k1.6%Plan not statedSEC
Sep 22, 2021Ajer Jeffrey RobertDirectorForm 4 sale3,665$65k10.1%Plan not statedSEC
Sep 9, 2021Chess RobertDirectorForm 4 sale18,279$293k6.2%Plan not statedSEC
Aug 17, 2021Labrucherie Gil MSVP, COO & CFOForm 4 sale10,867$149k4.3%Plan not statedSEC
Aug 16, 2021Zalevsky JonathanChief R&D OfficerForm 4 sale7,662$106k3.5%Plan not statedSEC
Aug 16, 2021Wilson Mark AndrewSVP & General CounselForm 4 sale1,910$26k2.6%Plan not statedSEC
Aug 16, 2021Robin Howard WPresident & CEOForm 4 sale11,515$159k2.6%Plan not statedSEC
Aug 16, 2021Thomsen Jillian B.SVP & Chief Accounting OfficerForm 4 sale13,339$184k8.8%Plan not statedSEC
Aug 16, 2021Northcott JohnSVP & Chief Commercial OfficerForm 4 sale6,192$86k3.0%Plan not statedSEC
Jul 22, 2021Chess RobertDirectorForm 4 sale5,721$96k2.0%Plan not statedSEC
May 17, 2021Zalevsky JonathanChief R&D OfficerForm 4 sale31,111$569k11.7%Plan not statedSEC
May 17, 2021Wilson Mark AndrewSVP & General CounselForm 4 sale1,917$35k2.5%Plan not statedSEC
May 17, 2021Thomsen Jillian B.SVP & Chief Accounting OfficerForm 4 sale13,391$245k8.1%UnusualSEC
May 17, 2021Robin Howard WPresident & CEOForm 4 sale11,560$212k2.6%Plan not statedSEC
May 17, 2021Northcott JohnSVP & Chief Commercial OfficerForm 4 sale6,085$111k2.9%Plan not statedSEC
May 17, 2021Labrucherie Gil MSVP, COO & CFOForm 4 sale7,898$145k3.0%Plan not statedSEC
May 12, 2021Chess RobertDirectorForm 4 sale8,000$155k2.8%Plan not statedSEC
Apr 14, 2021Chess RobertDirectorForm 4 sale8,000$152k2.8%Plan not statedSEC
Feb 16, 2021Zalevsky JonathanChief R&D OfficerForm 4 sale24,141$540k8.3%Plan not statedSEC
Feb 16, 2021Wilson Mark AndrewSVP & General CounselForm 4 sale2,173$49k2.8%Plan not statedSEC
Feb 16, 2021Thomsen Jillian B.SVP & Chief Accounting OfficerForm 4 sale11,705$262k6.6%UnusualSEC
Feb 16, 2021Robin Howard WPresident & CEOForm 4 sale11,495$257k2.5%Plan not statedSEC
Feb 16, 2021Northcott JohnSVP & Chief Commercial OfficerForm 4 sale15,358$344k6.7%Plan not statedSEC
Feb 16, 2021Labrucherie Gil MSVP, COO & CFOForm 4 sale7,977$178k3.0%Plan not statedSEC
Feb 4, 2021Robin Howard WPresident & CEOForm 4 sale450,000$9M49.5%UnusualSEC
Feb 4, 2021Labrucherie Gil MSVP, COO & CFOForm 4 sale150,000$3M36.0%UnusualSEC
Feb 3, 2021Wilson Mark AndrewSVP & General CounselForm 4 sale5,344$104k6.3%UnusualSEC
Jan 28, 2021Thomsen Jillian B.SVP & Chief Accounting OfficerForm 4 sale75,000$1.4M29.8%UnusualSEC
Dec 15, 2020Myriam CuretDirectorForm 4 sale1,560$28k7.5%Plan not statedSEC
Nov 23, 2020Zalevsky JonathanChief R&D OfficerForm 4 sale16,380$269k6.1%UnusualSEC
Nov 16, 2020Zalevsky JonathanChief R&D OfficerForm 4 sale29,618$501k10.0%UnusualSEC
Nov 16, 2020Wilson Mark AndrewSVP & General CounselForm 4 sale1,539$26k3.0%Plan not statedSEC
Nov 16, 2020Thomsen Jillian B.SVP & Chief Accounting OfficerForm 4 sale11,976$203k7.0%UnusualSEC
Nov 16, 2020Robin Howard WPresident & CEOForm 4 sale11,975$203k3.3%Plan not statedSEC
Nov 16, 2020Labrucherie Gil MSVP, COO & CFOForm 4 sale8,276$140k3.5%Plan not statedSEC
Sep 28, 2020Ajer Jeffrey RobertDirectorForm 4 sale3,250$56k11.1%Plan not statedSEC
Sep 25, 2020Chess RobertDirectorForm 4 sale5,500$98k1.9%Plan not statedSEC
Sep 21, 2020Ajer Jeffrey RobertDirectorForm 4 sale2,250$44k10.1%Plan not statedSEC
Sep 17, 2020Labrucherie Gil MSVP, COO & CFOForm 4 sale2,000$40k0.8%Plan not statedSEC
Sep 8, 2020Chess RobertDirectorForm 4 sale8,000$148k2.8%Plan not statedSEC
Aug 18, 2020Labrucherie Gil MSVP, COO & CFOForm 4 sale8,245$162k3.4%Plan not statedSEC
Aug 17, 2020Zalevsky JonathanChief R&D OfficerForm 4 sale26,200$515k8.1%UnusualSEC
Aug 17, 2020Wilson Mark AndrewSVP & General CounselForm 4 sale1,529$30k2.9%Plan not statedSEC
Aug 17, 2020Thomsen Jillian B.SVP & Chief Accounting OfficerForm 4 sale1,367$27k0.8%Plan not statedSEC
Aug 17, 2020Robin Howard WPresident & CEOForm 4 sale11,885$234k3.2%Plan not statedSEC
Jul 9, 2020Greer R ScottDirectorForm 4 sale15,009$375k7.8%Plan not statedSEC
Jul 8, 2020Chess RobertDirectorForm 4 sale8,000$197k2.8%Plan not statedSEC
May 19, 2020Labrucherie Gil MSVP, COO & CFOForm 4 sale7,727$174k3.1%Plan not statedSEC
May 18, 2020Zalevsky JonathanChief R&D OfficerForm 4 sale4,558$103k1.4%Plan not statedSEC
May 18, 2020Wilson Mark AndrewSVP & General CounselForm 4 sale1,529$34k2.8%Plan not statedSEC
May 18, 2020Thomsen Jillian B.SVP & Chief Accounting OfficerForm 4 sale1,367$31k0.8%Plan not statedSEC
May 18, 2020Robin Howard WPresident & CEOForm 4 sale8,968$202k2.3%Plan not statedSEC
Apr 15, 2020Chess RobertDirectorForm 4 sale8,000$147k2.8%Plan not statedSEC
Mar 11, 2020Chess RobertDirectorForm 4 sale8,000$134k2.8%Plan not statedSEC
Feb 18, 2020Zalevsky JonathanChief R&D OfficerForm 4 sale4,774$107k1.4%Plan not statedSEC
Feb 18, 2020Thomsen Jillian B.SVP & Chief Accounting OfficerForm 4 sale1,394$31k0.8%Plan not statedSEC
Feb 18, 2020Robin Howard WPresident & CEOForm 4 sale8,448$189k2.1%Plan not statedSEC
Feb 18, 2020Labrucherie Gil MSVP, COO & CFOForm 4 sale5,938$133k2.3%Plan not statedSEC
Feb 12, 2020Chess RobertDirectorForm 4 sale8,000$188k2.8%Plan not statedSEC
Feb 6, 2020Thomsen Jillian B.SVP & Chief Accounting OfficerForm 4 sale37,500$854k17.6%UnusualSEC
Nov 18, 2019Zalevsky JonathanChief R&D OfficerForm 4 sale3,960$71k1.3%Plan not statedSEC
Nov 18, 2019Thomsen Jillian B.SVP & Chief Accounting OfficerForm 4 sale2,713$49k1.7%Plan not statedSEC
Nov 18, 2019Robin Howard WPresident & CEOForm 4 sale13,556$244k4.3%Plan not statedSEC
Nov 18, 2019Labrucherie Gil MSVP, COO & CFOForm 4 sale8,863$159k3.9%Plan not statedSEC
Nov 13, 2019Labrucherie Gil MSVP, COO & CFOForm 4 sale25,000$495k9.9%Plan not statedSEC
Oct 17, 2019Robin Howard WPresident & CEOForm 4 sale100,000$1.7M24.2%Plan not statedSEC
Oct 15, 2019Labrucherie Gil MSVP, COO & CFOForm 4 sale25,000$396k9.9%UnusualSEC
Sep 30, 2019Ajer Jeffrey RobertDirectorForm 4 sale2,375$43k9.6%Plan not statedSEC
Sep 27, 2019Lingnau LutzDirectorForm 4 sale3,000$54k10.1%Plan not statedSEC
Sep 27, 2019Chess RobertDirectorForm 4 sale4,000$72k1.4%Plan not statedSEC
Sep 20, 2019Ajer Jeffrey RobertDirectorForm 4 sale2,250$46k11.0%Plan not statedSEC
Sep 16, 2019Labrucherie Gil MSVP & Chief Financial OfficerForm 4 sale25,000$513k14.1%UnusualSEC
Aug 16, 2019Thomsen Jillian B.SVP & Chief Accounting OfficerForm 4 sale1,809$33k1.1%Plan not statedSEC
Aug 16, 2019Robin Howard WPresident & CEOForm 4 sale12,551$228k4.2%Plan not statedSEC
Aug 16, 2019Nicholson JohnSVP & Chief Operating OfficerForm 4 sale3,819$69k2.3%Plan not statedSEC
Aug 16, 2019Labrucherie Gil MSVP & Chief Financial OfficerForm 4 sale5,063$92k4.0%Plan not statedSEC
Aug 16, 2019Doberstein Stephen KSVP & Chief Scientific OfficerForm 4 sale3,245$59k3.4%Plan not statedSEC
Aug 14, 2019Labrucherie Gil MSVP & Chief Financial OfficerForm 4 sale25,000$445k16.3%UnusualSEC
Jul 25, 2019Robin Howard WPresident & CEOForm 4 sale100,000$3.1M25.3%UnusualSEC
Jul 10, 2019Labrucherie Gil MSVP & Chief Financial OfficerForm 4 sale25,000$864k16.3%UnusualSEC
Jul 8, 2019Lingnau LutzDirectorForm 4 sale10,000$346k30.1%UnusualSEC
Jun 17, 2019Labrucherie Gil MSVP & Chief Financial OfficerForm 4 sale25,000$843k16.3%UnusualSEC
May 23, 2019Robin Howard WPresident & CEOForm 4 sale100,000$3.3M25.3%UnusualSEC
May 16, 2019Thomsen Jillian B.SVP & Chief Accounting OfficerForm 4 sale1,928$60k1.2%Plan not statedSEC
May 16, 2019Robin Howard WPresident & CEOForm 4 sale13,383$420k4.3%Plan not statedSEC
May 16, 2019Nicholson JohnSVP & Chief Operating OfficerForm 4 sale4,077$128k2.4%Plan not statedSEC
May 16, 2019Labrucherie Gil MSVP & Chief Financial OfficerForm 4 sale3,767$118k2.9%Plan not statedSEC
May 16, 2019Hora ManinderSVP Pharma Dev & Mfg OpsForm 4 sale2,449$77k2.5%Plan not statedSEC
May 16, 2019Doberstein Stephen KSVP & Chief Scientific OfficerForm 4 sale3,461$109k3.5%Plan not statedSEC
Feb 21, 2019Robin Howard WPresident & CEOForm 4 sale108,882$4.6M26.1%UnusualSEC
Feb 19, 2019Thomsen Jillian B.SVP & Chief Accounting OfficerForm 4 sale1,808$77k1.1%Plan not statedSEC
Feb 19, 2019Nicholson JohnSVP & Chief Operating OfficerForm 4 sale3,822$162k2.2%Plan not statedSEC
Feb 19, 2019Labrucherie Gil MSVP & Chief Financial OfficerForm 4 sale3,592$152k2.7%Plan not statedSEC
Feb 19, 2019Hora ManinderSVP Pharma Dev & Mfg OpsForm 4 sale2,386$101k2.4%Plan not statedSEC
Feb 19, 2019Doberstein Stephen KSVP & Chief Scientific OfficerForm 4 sale3,310$140k3.2%Plan not statedSEC
Feb 4, 2019Thomsen Jillian B.SVP & Chief Accounting OfficerForm 4 sale16,119$680k8.7%UnusualSEC
Jan 28, 2019Nicholson JohnSVP & Chief Operating OfficerForm 4 sale63,000$2.7M26.5%UnusualSEC
Nov 16, 2018Thomsen Jillian B.SVP & Chief Accounting OfficerForm 4 sale4,016$154k2.5%Plan not statedSEC
Nov 16, 2018Robin Howard WPresident & CEOForm 4 sale15,326$586k5.8%Plan not statedSEC
Nov 16, 2018Nicholson JohnSVP & Chief Operating OfficerForm 4 sale5,982$229k3.3%Plan not statedSEC
Nov 16, 2018Labrucherie Gil MSVP & Chief Financial OfficerForm 4 sale6,515$249k5.8%Plan not statedSEC
Nov 16, 2018Hora ManinderSVP Pharma Dev & Mfg OpsForm 4 sale4,694$180k5.5%Plan not statedSEC
Nov 16, 2018Doberstein Stephen KSVP & Chief Scientific OfficerForm 4 sale4,524$173k5.4%Plan not statedSEC
Sep 20, 2018Lingnau LutzDirectorForm 4 sale9,000$513k32.8%UnusualSEC
Sep 20, 2018Ajer Jeffrey RobertDirectorForm 4 sale6,750$383k30.0%UnusualSEC
Sep 19, 2018Chess RobertDirectorForm 4 sale4,500$256k1.6%Plan not statedSEC
Sep 4, 2018Greer R ScottDirectorForm 4 sale10,000$674k7.1%Plan not statedSEC
Aug 21, 2018Winger Dennis LDirectorForm 4 sale30,000$1.8M41.2%UnusualSEC
Aug 14, 2018Winger Dennis LDirectorForm 4 sale34,250$2.1M44.5%UnusualSEC
Jun 27, 2018Robin Howard WPresident & CEOForm 4 sale130,000$6.4M36.7%UnusualSEC
Jun 6, 2018Greer R ScottDirectorForm 4 sale10,000$603k7.1%Plan not statedSEC
Jun 5, 2018Chess RobertDirectorForm 4 sale10,000$552k3.5%Plan not statedSEC
May 16, 2018Thomsen Jillian B.SVP & Chief Accounting OfficerForm 4 sale3,576$298k5.2%Plan not statedSEC
May 16, 2018Robin Howard WPresident & CEOForm 4 sale12,791$1.1M5.4%Plan not statedSEC
May 16, 2018Nicholson JohnSVP & Chief Operating OfficerForm 4 sale4,917$410k2.9%Plan not statedSEC
May 16, 2018Labrucherie Gil MSVP & Chief Financial OfficerForm 4 sale4,941$412k5.0%Plan not statedSEC
May 16, 2018Hora ManinderSVP Pharma Dev & Mfg OpsForm 4 sale4,060$339k5.1%Plan not statedSEC
May 16, 2018Doberstein Stephen KSVP & Chief Scientific OfficerForm 4 sale3,435$286k5.1%Plan not statedSEC
May 3, 2018Chess RobertDirectorForm 4 sale25,000$2.1M8.4%UnusualSEC
May 3, 2018Labrucherie Gil MSVP & Chief Financial OfficerForm 4 sale90,000$7.6M47.4%UnusualSEC
May 3, 2018Robin Howard WPresident & CEOForm 4 sale130,000$10.9M35.4%UnusualSEC
Apr 16, 2018Thomsen Jillian B.SVP & Chief Accounting OfficerForm 4 sale13,881$1.4M16.8%UnusualSEC
Apr 10, 2018Hora ManinderSVP Pharma Dev & Mfg OpsForm 4 sale502$53k0.6%Plan not statedSEC
Apr 9, 2018Hora ManinderSVP Pharma Dev & Mfg OpsForm 4 sale29,498$3M26.9%UnusualSEC
Apr 9, 2018Doberstein Stephen KSVP & Chief Scientific OfficerForm 4 sale160,000$14.9M70.4%UnusualSEC
Apr 6, 2018Greer R ScottDirectorForm 4 sale30,000$2.8M18.7%Plan not statedSEC
Apr 6, 2018Chess RobertDirectorForm 4 sale25,000$2.3M8.4%UnusualSEC
Apr 5, 2018Lingnau LutzDirectorForm 4 sale30,000$3.1M52.2%UnusualSEC
Mar 7, 2018Kuebler Christopher ADirectorForm 4 sale40,000$3.9M49.7%UnusualSEC
Mar 7, 2018Nicholson JohnSVP & Chief Operating OfficerForm 4 sale220,144$21.9M56.8%UnusualSEC
Feb 16, 2018Thomsen Jillian B.SVP & Chief Accounting OfficerForm 4 sale2,545$211k3.6%Plan not statedSEC
Feb 16, 2018Robin Howard WPresident & CEOForm 4 sale12,788$1.1M5.1%Plan not statedSEC
Feb 16, 2018Nicholson JohnSVP & Chief Operating OfficerForm 4 sale4,879$405k1.2%Plan not statedSEC
Feb 16, 2018Labrucherie Gil MSVP & Chief Financial OfficerForm 4 sale3,477$288k3.4%Plan not statedSEC
Feb 16, 2018Hora ManinderSVP Pharma Dev & Mfg OpsForm 4 sale2,875$238k3.5%Plan not statedSEC
Feb 16, 2018Doberstein Stephen KSVP & Chief Scientific OfficerForm 4 sale2,426$201k3.5%Plan not statedSEC
Jan 22, 2018Robin Howard WPresident & CEOForm 4 sale83,333$6.3M25.0%UnusualSEC
Jan 2, 2018Kuebler Christopher ADirectorForm 4 sale30,000$1.8M42.6%UnusualSEC
Dec 13, 2017Robin Howard WPresident & CEOForm 4 sale83,333$4.6M30.6%UnusualSEC
Nov 13, 2017Nicholson JohnSVP & Chief Operating OfficerForm 4 sale15,910$601k6.4%UnusualSEC
Nov 8, 2017Doberstein Stephen KSVP & Chief Scientific OfficerForm 4 sale396,323$11.5M92.7%UnusualSEC
Nov 6, 2017Hora ManinderSVP Pharma Dev & Mfg OpsForm 4 sale5,117$128k8.1%Plan not statedSEC
Nov 1, 2017Robin Howard WPresident & CEOForm 4 sale83,334$2M35.3%UnusualSEC
Oct 9, 2017Robin Howard WPresident & CEOForm 4 sale83,333$2M35.3%UnusualSEC
Oct 5, 2017Hora ManinderSVP Pharma Dev & Mfg OpsForm 4 sale7,583$190k11.5%Plan not statedSEC
Oct 5, 2017Doberstein Stephen KSVP & Chief Scientific OfficerForm 4 sale43,677$1.1M58.4%UnusualSEC
Oct 2, 2017Labrucherie Gil MSVP & Chief Financial OfficerForm 4 sale120,000$2.9M65.4%UnusualSEC
Oct 2, 2017Gergel Ivan P.SVP & Chief Medical OfficerForm 4 sale100,000$2.4M70.6%UnusualSEC
Sep 22, 2017Lingnau LutzDirectorForm 4 sale5,000$110k15.4%Plan not statedSEC
Sep 22, 2017Kuebler Christopher ADirectorForm 4 sale4,000$87k9.0%Plan not statedSEC
Sep 21, 2017Chess RobertDirectorForm 4 sale6,400$139k2.3%Plan not statedSEC
Sep 6, 2017Robin Howard WPresident & CEOForm 4 sale83,333$1.8M35.3%UnusualSEC
Aug 16, 2017Thomsen Jillian B.SVP & Chief Accounting OfficerForm 4 sale2,648$51k5.0%Plan not statedSEC
Aug 16, 2017Robin Howard WPresident & CEOForm 4 sale91,714$1.8M37.6%UnusualSEC
Aug 16, 2017Nicholson JohnSVP & Chief Operating OfficerForm 4 sale3,177$61k1.4%Plan not statedSEC
Aug 16, 2017Labrucherie Gil MSVP & Chief Financial OfficerForm 4 sale3,177$61k4.8%Plan not statedSEC
Aug 16, 2017Hora ManinderSVP Pharma Dev & Mfg OpsForm 4 sale2,956$57k4.8%Plan not statedSEC
Aug 16, 2017Gergel Ivan P.SVP & Chief Medical OfficerForm 4 sale1,997$39k4.6%Plan not statedSEC
Aug 16, 2017Doberstein Stephen KSVP & Chief Scientific OfficerForm 4 sale1,701$33k5.2%Plan not statedSEC
Jul 18, 2017Gergel Ivan P.SVP & Chief Medical OfficerForm 4 sale54,920$1.2M55.8%UnusualSEC
Jul 14, 2017Lingnau LutzDirectorForm 4 sale30,000$623k56.1%UnusualSEC
Jul 12, 2017Gergel Ivan P.SVP & Chief Medical OfficerForm 4 sale45,080$950k50.9%UnusualSEC
Jun 7, 2017Nicholson JohnSVP & Chief Operating OfficerForm 4 sale101,700$2M30.9%UnusualSEC
May 16, 2017Thomsen Jillian B.SVP & Chief Accounting OfficerForm 4 sale2,651$52k4.8%Plan not statedSEC
May 16, 2017Robin Howard WPresident & CEOForm 4 sale8,388$164k5.0%Plan not statedSEC
May 16, 2017Nicholson JohnSVP & Chief Operating OfficerForm 4 sale3,146$62k1.7%Plan not statedSEC
May 16, 2017Labrucherie Gil MSVP & Chief Financial OfficerForm 4 sale3,179$62k4.6%Plan not statedSEC
May 16, 2017Hora ManinderSVP Pharma Dev & Mfg OpsForm 4 sale2,959$58k4.6%Plan not statedSEC
May 16, 2017Gergel Ivan P.SVP & Chief Medical OfficerForm 4 sale1,450$28k3.2%Plan not statedSEC
May 16, 2017Doberstein Stephen KSVP & Chief Scientific OfficerForm 4 sale1,701$33k4.9%Plan not statedSEC
May 15, 2017Chess RobertDirectorForm 4 sale5,000$99k1.8%Plan not statedSEC
Apr 17, 2017Chess RobertDirectorForm 4 sale5,000$94k1.8%Plan not statedSEC
Apr 7, 2017Lingnau LutzDirectorForm 4 sale7,000$140k23.0%Plan not statedSEC
Apr 5, 2017Doberstein Stephen KSVP & Chief Scientific OfficerForm 4 sale100,000$2.2M74.3%UnusualSEC
Apr 5, 2017Hora ManinderSVP Pharma Dev & Mfg OpsForm 4 sale180,000$3.9M73.9%UnusualSEC
Apr 5, 2017Kuebler Christopher ADirectorForm 4 sale15,000$328k29.7%UnusualSEC
Mar 20, 2017Thomsen Jillian B.SVP & Chief Accounting OfficerForm 4 sale112,500$2.2M66.9%UnusualSEC
Mar 14, 2017Chess RobertDirectorForm 4 sale5,000$77k1.8%Plan not statedSEC
Mar 3, 2017Labrucherie Gil MSVP & Chief Financial OfficerForm 4 sale200,000$3M74.3%UnusualSEC
Feb 21, 2017Lingnau LutzDirectorForm 4 sale30,000$392k49.6%UnusualSEC
Feb 16, 2017Thomsen Jillian B.SVP & Chief Accounting OfficerForm 4 sale1,965$26k3.4%Plan not statedSEC
Feb 16, 2017Robin Howard WPresident & CEOForm 4 sale8,636$113k4.9%Plan not statedSEC
Feb 16, 2017Nicholson JohnSVP & Chief Operating OfficerForm 4 sale3,237$43k1.7%Plan not statedSEC
Feb 16, 2017Labrucherie Gil MSVP & Chief Financial OfficerForm 4 sale2,359$31k3.3%Plan not statedSEC
Feb 16, 2017Hora ManinderSVP Pharma Dev & Mfg OpsForm 4 sale2,195$29k3.3%Plan not statedSEC
Feb 16, 2017Gergel Ivan P.SVP & Chief Medical OfficerForm 4 sale1,457$19k3.1%Plan not statedSEC
Feb 16, 2017Doberstein Stephen KSVP & Chief Scientific OfficerForm 4 sale1,261$17k3.5%Plan not statedSEC
Feb 8, 2017Robin Howard WPresident & CEOForm 4 sale87,500$1.1M33.0%UnusualSEC
Feb 3, 2017Nicholson JohnSVP & Chief Operating OfficerForm 4 sale75,000$929k34.8%UnusualSEC
Jan 17, 2017Robin Howard WPresident & CEOForm 4 sale87,500$1.1M33.0%UnusualSEC
Dec 7, 2016Robin Howard WPresident & CEOForm 4 sale87,500$1.1M41.6%UnusualSEC
Nov 17, 2016Robin Howard WPresident & CEOForm 4 sale93,458$1.3M43.2%UnusualSEC
Nov 16, 2016Thomsen Jillian B.SVP & Chief Accounting OfficerForm 4 sale1,986$28k4.5%Plan not statedSEC
Nov 16, 2016Nicholson JohnSVP & Chief Operating OfficerForm 4 sale1,654$23k1.4%Plan not statedSEC
Nov 16, 2016Labrucherie Gil MSVP & Chief Financial OfficerForm 4 sale1,654$23k3.1%Plan not statedSEC
Nov 16, 2016Hora ManinderSVP Pharma Dev & Mfg OpsForm 4 sale1,654$23k3.2%Plan not statedSEC
Nov 16, 2016Gergel Ivan P.SVP & Chief Medical OfficerForm 4 sale848$12k3.1%Plan not statedSEC
Nov 16, 2016Doberstein Stephen KSVP & Chief Scientific OfficerForm 4 sale670$9k3.5%Plan not statedSEC
Oct 4, 2016Robin Howard WPresident & CEOForm 4 sale87,500$1.5M40.4%UnusualSEC
Sep 16, 2016Kuebler Christopher ADirectorForm 4 sale7,500$143k21.4%Plan not statedSEC
Sep 15, 2016Lingnau LutzDirectorForm 4 sale9,000$172k54.7%UnusualSEC
Sep 15, 2016Chess RobertDirectorForm 4 sale12,000$231k4.6%Plan not statedSEC
Sep 1, 2016Robin Howard WPresident & CEOForm 4 sale87,500$1.6M40.4%UnusualSEC
Aug 16, 2016Nicholson JohnSVP & Chief Operating OfficerForm 4 sale3,317$58k2.6%UnusualSEC
Aug 16, 2016Thomsen Jillian B.SVP & Chief Accounting OfficerForm 4 sale3,971$70k8.3%Plan not statedSEC
Aug 16, 2016Robin Howard WPresident & CEOForm 4 sale11,817$208k8.4%Plan not statedSEC
Aug 16, 2016Labrucherie Gil MSVP & Chief Financial OfficerForm 4 sale3,305$58k5.9%Plan not statedSEC
Aug 16, 2016Hora ManinderSVP Pharma Dev & Mfg OpsForm 4 sale3,305$58k6.0%Plan not statedSEC
Aug 16, 2016Gergel Ivan P.SVP & Chief Medical OfficerForm 4 sale1,685$30k5.8%Plan not statedSEC
Aug 16, 2016Doberstein Stephen KSVP & Chief Scientific OfficerForm 4 sale1,336$23k6.6%Plan not statedSEC
Aug 1, 2016Chess RobertDirectorForm 4 sale5,000$86k1.9%Plan not statedSEC
Jul 11, 2016Thomsen Jillian B.SVP & Chief Accounting OfficerForm 4 sale100,000$1.5M93.6%UnusualSEC
Jul 1, 2016Chess RobertDirectorForm 4 sale5,000$71k1.9%Plan not statedSEC
Jun 1, 2016Chess RobertDirectorForm 4 sale5,000$78k1.9%Plan not statedSEC
May 17, 2016Nicholson JohnSVP & Chief Financial OfficerForm 4 sale856$12k1.1%Plan not statedSEC
May 17, 2016Robin Howard WPresident & CEOForm 4 sale2,170$29k11.4%Plan not statedSEC
May 17, 2016Doberstein Stephen KSVP & Chief Scientific OfficerForm 4 sale339$5k24.9%Plan not statedSEC
May 17, 2016Gergel Ivan P.SVP & Chief Medical OfficerForm 4 sale432$6k22.2%Plan not statedSEC
May 17, 2016Hora ManinderSVP Pharma Dev & Mfg OpsForm 4 sale835$11k10.5%Plan not statedSEC
May 17, 2016Labrucherie Gil MSVP & General CounselForm 4 sale836$11k9.5%Plan not statedSEC
May 17, 2016Thomsen Jillian B.SVP & Chief Accounting OfficerForm 4 sale724$10k10.3%Plan not statedSEC
Apr 25, 2016Lingnau LutzDirectorForm 4 sale15,000$244k47.7%UnusualSEC
Mar 9, 2016Thomsen Jillian B.SVP & Chief Accounting OfficerForm 4 sale15,000$177k74.4%UnusualSEC
Feb 17, 2016Gergel Ivan P.SVP & Chief Medical OfficerForm 4 sale556$7k44.5%UnusualSEC
Feb 17, 2016Nicholson JohnSVP & Chief Financial OfficerForm 4 sale963$11k1.2%Plan not statedSEC
Feb 17, 2016Robin Howard WPresident & CEOForm 4 sale2,147$26k13.7%Plan not statedSEC
Feb 17, 2016Doberstein Stephen KSVP & Chief Scientific OfficerForm 4 sale390$5k44.6%UnusualSEC
Feb 17, 2016Thomsen Jillian B.SVP & Chief Accounting OfficerForm 4 sale716$9k12.2%Plan not statedSEC
Feb 17, 2016Labrucherie Gil MSVP & General CounselForm 4 sale827$10k11.2%Plan not statedSEC
Feb 17, 2016Hora ManinderSVP Pharma Dev & Mfg OpsForm 4 sale963$11k14.2%Plan not statedSEC
Feb 10, 2016Labrucherie Gil MSVP & General CounselForm 4 sale11,666$134k69.0%UnusualSEC
Feb 10, 2016Thomsen Jillian B.SVP & Chief Accounting OfficerForm 4 sale15,000$172k79.0%UnusualSEC
Feb 10, 2016Robin Howard WPresident & CEOForm 4 sale66,666$766k87.0%UnusualSEC
Jan 20, 2016Lingnau LutzDirectorForm 4 sale15,000$218k47.7%UnusualSEC
Jan 19, 2016Thomsen Jillian B.SVP & Chief Accounting OfficerForm 4 sale15,000$212k79.0%UnusualSEC
Jan 19, 2016Robin Howard WPresident & CEOForm 4 sale66,667$941k87.0%UnusualSEC
Jan 19, 2016Labrucherie Gil MSVP & General CounselForm 4 sale11,667$165k69.0%UnusualSEC
Dec 4, 2015Kuebler Christopher ADirectorForm 4 sale15,000$237k42.9%UnusualSEC
Dec 3, 2015Labrucherie Gil MSVP & General CounselForm 4 sale45,001$714k89.6%UnusualSEC
Dec 3, 2015Robin Howard WPresident & CEOForm 4 sale125,001$2M92.6%UnusualSEC
Dec 3, 2015Thomsen Jillian B.SVP & Chief Accounting OfficerForm 4 sale15,000$238k79.0%UnusualSEC
Nov 20, 2015Wang SusanDirectorForm 4 sale85,000$1.3M81.0%UnusualSEC
Nov 11, 2015Robin Howard WPresident & CEOForm 4 sale125,000$1.7M92.6%UnusualSEC
Nov 11, 2015Labrucherie Gil MSVP & General CounselForm 4 sale45,000$608k90.5%UnusualSEC
Nov 11, 2015Thomsen Jillian B.SVP & Chief Accounting OfficerForm 4 sale15,000$203k81.1%UnusualSEC
Oct 28, 2015Lingnau LutzDirectorForm 4 sale12,500$150k43.2%UnusualSEC
Oct 6, 2015Robin Howard WPresident & CEOForm 4 sale125,000$1.4M92.6%UnusualSEC
Oct 6, 2015Labrucherie Gil MSVP & General CounselForm 4 sale45,000$495k90.5%UnusualSEC
Oct 6, 2015Thomsen Jillian B.SVP & Chief Accounting OfficerForm 4 sale15,000$165k81.1%UnusualSEC
Sep 23, 2015Thomsen Jillian B.SVP & Chief Accounting OfficerForm 4 sale10,000$130k74.1%UnusualSEC
Sep 23, 2015Robin Howard WPresident & CEOForm 4 sale124,999$1.6M92.6%UnusualSEC
Sep 23, 2015Labrucherie Gil MSVP & General CounselForm 4 sale44,999$587k90.5%UnusualSEC
Aug 13, 2015Labrucherie Gil MSVP & General CounselForm 4 sale33,333$363k87.5%UnusualSEC
Aug 13, 2015Robin Howard WPresident & CEOForm 4 sale58,333$635k85.4%UnusualSEC
Aug 12, 2015Nicholson JohnSVP & Chief Financial OfficerForm 4 sale319,884$3.4M81.0%UnusualSEC
Jul 14, 2015Robin Howard WPresident & CEOForm 4 sale58,334$687k85.4%UnusualSEC
Jul 14, 2015Labrucherie Gil MSVP & General CounselForm 4 sale33,334$393k88.7%UnusualSEC
Jun 29, 2015Wang SusanDirectorForm 4 sale30,000$381k60.0%UnusualSEC
Jun 19, 2015Chess RobertDirectorForm 4 sale15,000$177k5.4%Plan not statedSEC
Jun 15, 2015Lingnau LutzDirectorForm 4 sale25,000$279k60.3%UnusualSEC
Jan 13, 2015Kuebler Christopher ADirectorForm 4 sale15,000$240k42.9%UnusualSEC
Dec 29, 2014Chess RobertDirectorForm 4 sale29,500$453k10.2%Plan not statedSEC
Dec 22, 2014Thomsen Jillian B.SVP & Chief Accounting OfficerForm 4 sale5,000$78k62.5%UnusualSEC
Dec 1, 2014Labrucherie Gil MSVP & General CounselForm 4 sale120,000$2M96.6%UnusualSEC
Dec 1, 2014Robin Howard WPresident & CEOForm 4 sale350,000$6M97.2%UnusualSEC
Nov 25, 2014Robin Howard WPresident & CEOForm 4 sale600,000$9.1M98.4%UnusualSEC
Nov 24, 2014Labrucherie Gil MSVP & General CounselForm 4 sale10,500$158k73.7%UnusualSEC
Nov 24, 2014Lingnau LutzDirectorForm 4 sale15,000$225k47.7%UnusualSEC
Nov 3, 2014Labrucherie Gil MSVP & General CounselForm 4 sale9,900$136k72.5%UnusualSEC
Aug 5, 2013Kuebler Christopher ADirectorForm 4 sale12,500$155k38.5%UnusualSEC
Aug 5, 2013Whitfield Roy ADirectorForm 4 sale12,500$155k38.5%UnusualSEC
Sep 27, 2012Kuebler Christopher ADirectorForm 4 sale12,500$133k38.5%UnusualSEC
Jul 13, 2012Chess RobertDirectorForm 4 sale24,001$204k8.4%Plan not statedSEC
Mar 8, 2011Chess RobertDirectorForm 4 sale4,500$41k1.7%Plan not statedSEC
May 10, 2010Chess RobertDirectorForm 4 sale35,000$488k12.1%Plan not statedSEC
May 12, 2009Labrucherie Gil MSVP & General CounselForm 4 sale395$2k12.9%Plan not statedSEC
May 12, 2009Thomsen Jillian B.VP & Chief Accounting OfficerForm 4 sale201$1k9.3%Plan not statedSEC
Nov 14, 2008Labrucherie Gil MSVP & General CounselForm 4 sale401$2k16.9%Plan not statedSEC
Nov 14, 2008Thomsen Jillian B.VP & Chief Accounting OfficerForm 4 sale203$88711.2%Plan not statedSEC
Nov 14, 2008Patton John StuartChief Scientific OfficerForm 4 sale760$3k0.2%Plan not statedSEC
Mar 22, 2007Chess RobertDirectorForm 4 sale17,700$216k6.8%Plan not statedSEC
Jan 8, 2007Chess RobertChairman, Pres. & CEOForm 4 sale3,592$52k1.7%Plan not statedSEC
May 15, 2006Patton John StuartChief Scientific OfficerForm 4 sale1,633$33k72.7%UnusualSEC
Mar 23, 2006Gill AjitOtherForm 4 sale3,545$70k3.9%Plan not statedSEC
Mar 10, 2006Bansal AjayOtherForm 4 sale5,167$103k50.0%UnusualSEC
Mar 7, 2006Chess RobertExecutive ChairmanForm 4 sale2,210$44k1.1%Plan not statedSEC
Mar 7, 2006Patton John StuartChief Scientific OfficerForm 4 sale3,859$76k0.7%Plan not statedSEC
Jan 27, 2006Gill AjitPresident & CEOForm 4 sale40,000$883k32.9%UnusualSEC
Jan 27, 2006Patton John StuartChief Scientific OfficerForm 4 sale20,000$440k3.5%Plan not statedSEC
Jan 13, 2006Patton John StuartChief Scientific OfficerForm 4 sale20,000$401k3.7%Plan not statedSEC